
PolyModels Hub is a digital platform designed specifically for pharmaceutical process development, offering advanced modeling, simulations, and data management solutions. Their flagship product, Model Flow, streamlines the entire lifecycle of drug development from initial design to product filing and launch, enabling teams to collaborate effectively and make informed decisions faster. The platform supports various therapeutic modalities and is backed by a team of experts with extensive experience in the life sciences sector. By leveraging their model-based workflows, clients can enhance their process design, optimize experimental outcomes, and achieve significant time-to-market advantages, positioning PolyModels Hub as a leader in the pharmaceutical technology space.

PolyModels Hub is a digital platform designed specifically for pharmaceutical process development, offering advanced modeling, simulations, and data management solutions. Their flagship product, Model Flow, streamlines the entire lifecycle of drug development from initial design to product filing and launch, enabling teams to collaborate effectively and make informed decisions faster. The platform supports various therapeutic modalities and is backed by a team of experts with extensive experience in the life sciences sector. By leveraging their model-based workflows, clients can enhance their process design, optimize experimental outcomes, and achieve significant time-to-market advantages, positioning PolyModels Hub as a leader in the pharmaceutical technology space.
Product: ModelFlow platform for pharma process development (modeling, simulation, data integration)
Headquarters: London, United Kingdom
Founded: 2023
Seed raise: £1.1M announced Jul 9, 2024 (lead: Marathon Venture Capital)
Founders: Antonio Benedetti; Charalampos (Harry) Christodoulou; Antonio Yankey
| Company |
|---|
Pharmaceutical process development, scale-up, and manufacturing optimization
2023
Biotechnology
£1.1M
Announced Seed round; company statement reports £1.1M
“Marathon Venture Capital (lead investor)”